Edition:
United States

Profile: Kalbe Farma Tbk PT (KLBF.JK)

KLBF.JK on Jakarta Stock Exchange

1,540.00IDR
2 Dec 2016
Change (% chg)

Rp. -50.00 (-3.14%)
Prev Close
Rp. 1,590.00
Open
Rp. 1,560.00
Day's High
Rp. 1,570.00
Day's Low
Rp. 1,520.00
Volume
60,119,700
Avg. Vol
32,538,735
52-wk High
Rp. 1,815.00
52-wk Low
Rp. 1,135.00

PT Kalbe Farma Tbk is an Indonesia-based company primarily engaged in manufacturing health and nutritional as well as pharmaceutical products. Its business is classified into four segments: prescription drugs, health products, nutritional products as well as distribution and logistics. Its prescription drugs segment manufactures unbranded generic, branded generic and patented drugs. Its health products segment offers over-the-counter (OTC) therapeutic drugs, consumer health products as well as energy and health drinks; some major brands under the segment are Woods, Procold, Extra Joss and Hydro Coco. Its nutritional products segment manufactures a range of products for infants, toddlers, children, teenagers, adults, expectant and lactating mothers as well as elderly; some of major brands under the segment are Prenagen, Milna, Diabetasol and Entrasol. The distribution and logistics segment is operated through its subsidiary, PT Enseval Putera Megatrading Tbk.

Company Address

Kalbe Farma Tbk PT

Gedung KALBE
Jl. Let. Jnd. Sprpto Kav. 4,Cmpk
P.O. Box 3105 JAK.
JAKARTA     10510
P: +6221.42873888
F: +6221.42873678

Company Web Links